Mycomycen (Ciclopirox Olamine)

Ciclopirox olamine, the active ingredient in Mycomycen, is an antifungal presented as a vaginal formulation for local use. It treats vaginal candidiasis, a yeast infection affecting women, by targeting fungal growth within the vaginal mucosa.

GNH USA supplies Mycomycen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mycomycen, an antifungal agent, is used to manage fungal infections of the vaginal tract.

Vaginal candidiasis: treatment of yeast infection in the vagina, reducing symptoms and eradicating the fungus.

Ciclopirox olamine may cause local adverse reactions when applied vaginally.

Common Side Effects: - Irritation or burning sensation at the application site - Itching or mild discomfort in the vaginal area - Unpleasant vaginal discharge or odor - Dryness or mild soreness

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling and difficulty breathing - Extensive vulvar or vaginal swelling, redness, or intense pain

Before using Mycomycen, consider the following precautions to ensure safe and effective therapy.

Allergy assessment: verify no known hypersensitivity to ciclopirox or formulation components. Pregnancy and lactation: consult a healthcare professional before use. Concurrent vaginal products: avoid using other intravaginal medications simultaneously. Medical conditions: inform the prescriber of any chronic vaginal disorders. Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Ciclopirox olamine can interact with other substances; awareness of potential interactions helps minimize risks.

Major Interactions (Avoid): - Concurrent use of other topical antifungal agents: may increase local irritation.

Moderate Interactions (Monitor Closely): - Use with hormonal contraceptives: no direct interaction but monitor efficacy. - Co‑administration with spermicidal products: may affect absorption. - Presence of severe vaginal inflammation: may alter drug performance.